Effect of Neonatal Hearing Screening Results on the Lost to Follow-Up at the Diagnostic Level
Abstract
:1. Introduction
2. Materials and Methods
3. Results
3.1. No RFs during the Neonatal Period and No RFs after the Neonatal Period
3.2. RFs of the Neonatal Period and No RFs after the Neonatal Period
3.3. No RFs during the Neonatal Period and RFs after the Neonatal Period
3.4. RFs during the Neonatal Period and RFs after the Neonatal Period
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Neumann, K.; Euler, H.; Chadha, S.; White, K.R. The International Newborn and Infant Hearing Screening (NIHS) Group. A survey on the global status of newborn and infant hearing screening. J. Early Hear. Detect. Intervent. 2020, 5, 63–84. [Google Scholar]
- Greczka, G.; Wróbel, M.; Dąbrowski, P.; Szyfter-Harris, J.; Szyfter, W. The role of the paediatrician in the Universal Neonatal Hearing Screening Program in Poland. Stand. Med. Pediatr. 2018, 2, 85–90. [Google Scholar]
- Greczka, G.; Zych, M.; Wróbel, M.; Szyfter-Harris, J.; Szyfter, W. Analysis of follow-up at the diagnostic level in the Polish Universal Neonatal Hearing Screening Programme. J. Med. Screen 2018, 25, 13–16. [Google Scholar] [CrossRef] [PubMed]
- Alam, S.; Gaffney, M.; Eichwald, J. Improved newborn hearing screening follow-up results in more infants identified. J. Public Health Manag. Pract. 2014, 20, 220–223. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Metzger, D.; Pezier, F.; Vergauth, D. Evaluation of universal newborn hearing screening in Switzerland 2012 and follow-up data for Zurich. Swiss Med. Wkly. 2013, 143, w13905. [Google Scholar] [CrossRef] [Green Version]
- Gaffney, M.; Green, D.; Gaffney, C. Newborn hearing screening and follow-up: Are children receiving recommended services? Public Health Rep. 2010, 125, 199–207. [Google Scholar] [CrossRef]
- American Academy of Paediatrics. Taskforce on Improving the Effectiveness of Newborn Hearing Screening, Diagnosis, and Intervention Strategic Plan. Available online: http://www.medicalhomeinfo.org/downloads/pdfs/AAP_EHDI_Strategic_Plan.pdf (accessed on 9 May 2013).
- Joint Committee on Infant Hearing. Year 2007 position statement: Principles and guidelines for early hearing detection and intervention programs. Paediatrics 2007, 120, 898–921. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sloot, F.; Hoeve, H.L.; De Kroon, M.L.; Goedegebure, A.; Carlton, J.; Griffiths, H.J.; Simonsz, H.J.; EUS€ REEN Study Group. Inventory of current EU paediatric vision and hearing screening programmes. J. Med. Screen 2015, 22, 55–64. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ravi, R.; Gunjawate, D.; Yerraguntla, K.; Lewis, L.E.; Driscoll, C.; Rajashekhar, B. Follow-up in newborn hearing screening—A systematic review. Int. J. Pediatr. Otorhinolaryngol. 2016, 90, 29–36. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Shulman, S.; Besculides, M.; Saltzman, A.; Ireys, H.; White, K.R.; Forsman, I. Evaluation of the universal newborn hearing screening and intervention program. Paediatrics 2010, 126 (Suppl. S1), S19–S27. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Neumann, K.; Nawka, T.; Wiesner, T.; Hess, M.; Böttcher, P.; Gross, M.; Autorengruppe im Auftrag der DGPP. Qualitätssicherung eines universellen Neugeborenen-Hörscreenings. HNO 2009, 57, 17–20. [Google Scholar] [CrossRef] [PubMed]
No RFs during the Neonatal Period and No RFs after the Neonatal Period | |||||||
Normal hearing | Hearing loss | % of hearing loss | Diagnosis | Without diagnosis | % without diagnosis | Total | |
Doubtful in both ears | 5936 | 165 | 2.7% | 6101 | 8500 | 58.2% | 14,601 |
Doubtful correct | 1177 | 128 | 9.8% | 1305 | 20,702 | 94.1% | 22,007 |
Doubtful control | 1743 | 130 | 6.9% | 1873 | 1737 | 48.1% | 3610 |
Correct in both ears | 89,801 | 1649 | 1.8% | 91,450 | 5,906,212 | 98.5% | 5,997,662 |
Correct Control | 45,398 | 2208 | 4.6% | 47,606 | 50,800 | 51.6% | 98,406 |
Control in both ears | 22,490 | 4160 | 15.6% | 26,650 | 27,719 | 51.0% | 54,369 |
Without OAE test | 31,184 | 957 | 3.0% | 32,141 | 80,950 | 71.6% | 113,091 |
No RFs during the neonatal period and RFs after the neonatal period | |||||||
Normal hearing | Hearing loss | % of hearing loss | Diagnosis | Without diagnosis | % without diagnosis | Total | |
Doubtful in both ears | 42 | 20 | 32.3% | 62 | 34 | 35.4% | 96 |
Doubtful correct | 47 | 18 | 27.7% | 65 | 41 | 38.7% | 106 |
Doubtful control | 27 | 11 | 28.9% | 38 | 9 | 19.1% | 47 |
Correct in both ears | 2496 | 170 | 6.4% | 2666 | 987 | 27.0% | 3653 |
Correct Control | 525 | 132 | 20.1% | 657 | 200 | 23.3% | 857 |
Control in both ears | 294 | 247 | 45.7% | 541 | 161 | 22.9% | 702 |
Without OAE test | 603 | 112 | 15.7% | 715 | 134 | 15.8% | 849 |
RFs during the neonatal period and no RFs after the neonatal period | |||||||
Normal hearing | Hearing loss | % of hearing loss | Diagnosis | Without diagnosis | % without diagnosis | Total | |
Doubtful in both ears | 745 | 110 | 12.9% | 855 | 1024 | 54.5% | 1879 |
Doubtful correct | 544 | 170 | 23.8% | 714 | 615 | 46.3% | 1329 |
Doubtful control | 166 | 79 | 32.2% | 245 | 225 | 47.9% | 470 |
Correct in both ears | 127,703 | 1724 | 1.3% | 129,427 | 96,251 | 42.6% | 225,678 |
Correct Control | 6032 | 781 | 11.5% | 6813 | 4632 | 40.5% | 11,445 |
Control in both ears | 4692 | 2299 | 32.9% | 6991 | 5803 | 45.4% | 12,794 |
Without OAE test | 5443 | 386 | 6.6% | 5829 | 4927 | 45.8% | 10,756 |
RFs during the neonatal period and RFs after the neonatal period | |||||||
Normal hearing | Hearing loss | % of hearing loss | Diagnosis | Without diagnosis | % without diagnosis | Total | |
Doubtful in both ears | 42 | 22 | 34.4% | 64 | 15 | 19.0% | 79 |
Doubtful correct | 22 | 21 | 48.8% | 43 | 5 | 10.4% | 48 |
Doubtful control | 18 | 9 | 33.3% | 27 | 1 | 3.6% | 28 |
Correct in both ears | 3884 | 181 | 4.5% | 4065 | 487 | 10.7% | 4552 |
Correct Control | 264 | 69 | 20.7% | 333 | 42 | 11.2% | 375 |
Control in both ears | 282 | 277 | 49.6% | 559 | 56 | 9.1% | 615 |
Without OAE test | 305 | 77 | 20.2% | 382 | 38 | 9.0% | 420 |
No RFs after the neonatal period | Risk of hearing loss no RFs during the neonatal period vs. RFs during the neonatal period | ||||||
OR | 95 % CI: | p-value | |||||
Doubtful in both ears | 5.31 | 4.12 to 6.84 | p < 0.0001 | ||||
Doubtful/correct | 2.87 | 2.24 to 3.69 | p < 0.0001 | ||||
Doubtful/control | 6.38 | 4.63 to 8.80 | p < 0.0001 | ||||
Correct in both ears | 0.74 | 0.69 to 0.79 | p < 0.0001 | ||||
Correct/control | 2.66 | 2.44 to 2.90 | p < 0.0001 | ||||
Control in both ears | 2.65 | 2.49 to 2.81 | p < 0.0001 | ||||
Without OAE test | 2.31 | 2.05 to 2.61 | p < 0.0001 | ||||
RFs after the neonatal period | Risk of hearing loss no RFs during the neonatal period vs. RFs during the neonatal period | ||||||
OR | 95 % CI: | p-value | |||||
Doubtful in both ears | 1.1 | 0.52 to 2.31 | p = 0.8011 | ||||
Doubtful/correct | 2.49 | 1.11 to 5.59 | p = 0.0267 | ||||
Doubtful/control | 1.23 | 0.42 to 3.56 | p = 0.7059 | ||||
Correct in both ears | 0.68 | 0.55 to 0.85 | p = 0.0006 | ||||
Correct/control | 1.04 | 0.75 to 1.44 | p = 0.8161 | ||||
Control in both ears | 1.17 | 0.92 to 1.48 | p = 0.1959 | ||||
Without OAE test | 1.36 | 0.99 to 1.87 | p = 0.0611 |
Descriptive Statistics | N | Minimum | Lower Quartile | Median | Upper Quartile | Maximum |
---|---|---|---|---|---|---|
No RFs during the neonatal period and no RFs after the neonatal period | 207,126 | 5.0 | 51.0 | 80.0 | 118.0 | 6389.0 (17.5 years) |
RFs during the neonatal period and no RFs after the neonatal period | 150,874 | 4.0 | 60.0 | 88.0 | 123.0 | 5471.0 (15.0 years) |
RFs during the neonatal period and RFs after the neonatal period | 5473 | 3.0 | 61.0 | 90.0 | 133.0 | 3435.0 (9.4 years) |
No RF during the neonatal period and RFs after the neonatal period | 4744 | 38.0 | 67.0 | 101.0 | 199.0 | 4906.0 (13.4 years) |
Total | 368,217 | 3.0 | 55.0 | 84.0 | 121.0 | 6389.0 (17.5 years) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Greczka, G.; Dąbrowski, P.; Zych, M.; Szyfter, W. Effect of Neonatal Hearing Screening Results on the Lost to Follow-Up at the Diagnostic Level. Healthcare 2023, 11, 1770. https://doi.org/10.3390/healthcare11121770
Greczka G, Dąbrowski P, Zych M, Szyfter W. Effect of Neonatal Hearing Screening Results on the Lost to Follow-Up at the Diagnostic Level. Healthcare. 2023; 11(12):1770. https://doi.org/10.3390/healthcare11121770
Chicago/Turabian StyleGreczka, Grażyna, Piotr Dąbrowski, Monika Zych, and Witold Szyfter. 2023. "Effect of Neonatal Hearing Screening Results on the Lost to Follow-Up at the Diagnostic Level" Healthcare 11, no. 12: 1770. https://doi.org/10.3390/healthcare11121770
APA StyleGreczka, G., Dąbrowski, P., Zych, M., & Szyfter, W. (2023). Effect of Neonatal Hearing Screening Results on the Lost to Follow-Up at the Diagnostic Level. Healthcare, 11(12), 1770. https://doi.org/10.3390/healthcare11121770